跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEFUZIN-B CREAM - HSA Drug Approval Details
Approvals
/
HSA
/
DEFUZIN-B CREAM
Approved
THERAPEUTIC
DEFUZIN-B CREAM
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 13, 2019
Approval ID
5aa7493a1b7ee92c
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
5aa7493a1b7ee92c
Drug Name
DEFUZIN-B CREAM
Product Name
DEFUZIN-B CREAM
Approval Number
SIN15684P
Approval Date
2019-05-13
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CREAM
Route Of Administration
TOPICAL
Atc Code
D07CC01
Atc Item Name
betamethasone and antibiotics
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
BETAMETHASONE-17- VALERATE 1.21mg/g EQV BETAMETHASONE (MICRONIZED)
1mg/g
FUSIDIC ACID (MICRONIZED)
20.0mg/g
BETAMETHASONE-17-VALERATE 1.21 MG/G EQV BETAMETHASONE (MICRONIZED)
1 MG/G
FUSIDIC ACID (MICRONIZED)
20 MG/G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 13, 2019
Approval ID
5aa7493a1b7ee92c
Type
Therapeutic
Back to HSA Approvals